Sign in
4

Changes in Ownership

Cogent Biosciences, Inc. Filed Acc 0001104659-26-005924

Director sold 3,500,000 shares at $36.40 ($127,400,000)

From the SEC's structured data for this filing

Trades in this filing

Fairmount Funds Management LLC · Director

Table I: Non-derivative

1 line
Date Transaction Shares Price Value Owned after D/I
2026-01-22 Sale : show line 1 in the form −3,500,000 $36.40 $127,400,000 5,503,418 I
Open-market sales · 3,500,000 sh · avg $36.40 · $127,400,000
Loading xslF345X05/tm263873-2_4seq1.xml…